61 related articles for article (PubMed ID: 31075227)
1. High GD2 expression defines breast cancer cells with enhanced invasiveness.
Mansoori M; Roudi R; Abbasi A; Abolhasani M; Abdi Rad I; Shariftabrizi A; Madjd Z
Exp Mol Pathol; 2019 Aug; 109():25-35. PubMed ID: 31075227
[TBL] [Abstract][Full Text] [Related]
2. TGFβ1 Promotes Breast Cancer Local Invasion and Liver Metastasis by Increasing the CD44
Zhang C; Gao H; Li C; Tu J; Chen Z; Su W; Geng X; Chen X; Wang J; Pan W
Technol Cancer Res Treat; 2018 Jan; 17():1533033818764497. PubMed ID: 29658391
[TBL] [Abstract][Full Text] [Related]
3. Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells.
Liang YJ; Ding Y; Levery SB; Lobaton M; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):4968-73. PubMed ID: 23479608
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitivity analysis and study of gene resistance on tumors and cancer stem cell isolates from patients with colorectal cancer.
Garza-Treviño EN; Martínez-Rodríguez HG; Delgado-González P; Solís-Coronado O; Ortíz-Lopez R; Soto-Domínguez A; Treviño VM; Padilla-Rivas GR; Islas-Cisneros JF; Quiroz-Reyes AG; Said-Fernández SL
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396431
[TBL] [Abstract][Full Text] [Related]
5. Role of CD44 and CD24 Expression on 2-years Disease Free Survival in Patients with Advanced Epithelial Ovarian Carcinoma.
Feharsal Y; Andrijono A; Singoprawiro CS; Lisnawati L; Pakasi TA; Putra AD; Kusuma F; Anggraeni TD; Erlina E; Sarwanti S; Mardhiyah T
Asian Pac J Cancer Prev; 2024 Feb; 25(2):513-519. PubMed ID: 38415537
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Expression of Autophagy-Related Marker (LC3B) and Stem Cell Marker (CD44) in Molecular Subtypes of Breast Cancer.
El-Deek HEM; El-Naggar MS; Sayed SG
Asian Pac J Cancer Prev; 2024 Jan; 25(1):145-152. PubMed ID: 38285778
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways.
Li M; Knight DA; Smyth MJ; Stewart TJ
Cancer Immunol Immunother; 2012 Aug; 61(8):1255-68. PubMed ID: 22270714
[TBL] [Abstract][Full Text] [Related]
8. Illuminating the lateral organization of cell-surface CD24 and CD44 through plasmon coupling between Au nanoparticle immunolabels.
Yu X; Wang J; Feizpour A; Reinhard BM
Anal Chem; 2013 Feb; 85(3):1290-4. PubMed ID: 23320416
[TBL] [Abstract][Full Text] [Related]
9. Stem cell markers: A guide to neoadjuvant therapy in breast carcinomas.
Gucin Z; Buyukpinarbasili N; Gecer MO; Ersoy YE; Turk HM; Yildiz S; Aksoy DO
Indian J Pathol Microbiol; 2023; 66(3):495-501. PubMed ID: 37530329
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of SOX2 and STAT3 expression on circulating T lymphocytes and CD44+/CD24
Sobral DV; Salgado MRT; Martins MR; Vasconcelos CS; Anunciação CEC; de Andrade VP; Torres LC
J Surg Oncol; 2024 Jun; ():. PubMed ID: 38825982
[TBL] [Abstract][Full Text] [Related]
11. Anti-IL-8 monoclonal antibodies inhibits the autophagic activity and cancer stem cells maintenance within breast cancer tumor microenvironment.
Abou Shousha S; Osman EM; Baheeg S; Shahine Y
Breast Dis; 2024; 43(1):37-49. PubMed ID: 38552109
[TBL] [Abstract][Full Text] [Related]
12. GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells.
Seitz CM; Schroeder S; Knopf P; Krahl AC; Hau J; Schleicher S; Martella M; Quintanilla-Martinez L; Kneilling M; Pichler B; Lang P; Atar D; Schilbach K; Handgretinger R; Schlegel P
Oncoimmunology; 2020; 9(1):1683345. PubMed ID: 32002293
[TBL] [Abstract][Full Text] [Related]
13. Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy.
Nazha B; Inal C; Owonikoko TK
Front Oncol; 2020; 10():1000. PubMed ID: 32733795
[TBL] [Abstract][Full Text] [Related]
14. Epithelial Ovarian Cancer: A Five Year Review.
Arnaoutoglou C; Dampala K; Anthoulakis C; Papanikolaou EG; Tentas I; Dragoutsos G; Machairiotis N; Zarogoulidis P; Ioannidis A; Matthaios D; Perdikouri EI; Giannakidis D; Sardeli C; Petousis S; Oikonomou P; Nikolaou C; Charalampidis C; Sapalidis K
Medicina (Kaunas); 2023 Jun; 59(7):. PubMed ID: 37511995
[TBL] [Abstract][Full Text] [Related]
15. Electrostatic potential difference between tumor and paratumor regulates cancer stem cell behavior and prognose tumor spread.
Zhao H; Zhang W; Tang X; Galan EA; Zhu Y; Sang G; Khutsishvili D; Zheng H; Ma S
Bioeng Transl Med; 2023 Mar; 8(2):e10399. PubMed ID: 36925705
[TBL] [Abstract][Full Text] [Related]
16. The biological role and immunotherapy of gangliosides and GD3 synthase in cancers.
Cao S; Hu X; Ren S; Wang Y; Shao Y; Wu K; Yang Z; Yang W; He G; Li X
Front Cell Dev Biol; 2023; 11():1076862. PubMed ID: 36824365
[TBL] [Abstract][Full Text] [Related]
17. A bibliometric analysis of the top 100 most cited papers and research trends in breast cancer related BRCA1 and BRCA2 genes.
Alkhayyat S; Khan M; Ahmad T; Haroon ; Tariq H; Baig M
Medicine (Baltimore); 2022 Sep; 101(38):e30576. PubMed ID: 36197199
[TBL] [Abstract][Full Text] [Related]
18. A cholesterogenic gene signature for predicting the prognosis of young breast cancer patients.
Li X; Zhou C; Qiu C; Li W; Yu Q; Huang H; Zhang Y; Zhang X; Ren L; Huang X; Zhou Q
PeerJ; 2022; 10():e13922. PubMed ID: 35999846
[TBL] [Abstract][Full Text] [Related]
19. Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma.
Blatt S; Krüger M; Rump C; Zimmer S; Sagheb K; Künzel J
PLoS One; 2022; 17(5):e0269136. PubMed ID: 35622885
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Ganglioside GD2 Synthase (GD2S), as a New Putative Cancer Stem Cell Marker in Breast Carcinomas.
Mansoori M; Mirzaei A; Abdi Rad I; Mahmodlou R; Mansouri F; Saeednejad Zanjani L; Asadi-Lari Z; Madjd Z
Med J Islam Repub Iran; 2021; 35():148. PubMed ID: 35321364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
